Defendant entity record
Abbott Laboratories lawsuits
Abbott Laboratories is a defendant in the preterm infant formula and NEC litigation. As of October 1, 2026, 844 actions were pending in federal MDL 3026. The count covers the MDL, not just claims against Abbott.
Claims in these lawsuits are allegations until a court or settlement resolves them.
Key facts
| Cases we track | 1 |
|---|
The entity record
- Fact 1
- 844 pending actions in MDL 3026 (October 1, 2026)
- Source: https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-October-1-2026.pdf
- Fact 2
- MDL-3026 — N.D. Ill., Judge Rebecca R. Pallmeyer
- Source: https://www.jpml.uscourts.gov/
The NEC litigation alleges that cow's-milk-based formulas fed to premature infants raised the risk of necrotizing enterocolitis, and that manufacturers failed to warn parents and clinicians. Federal cases are consolidated as MDL-3026 (N.D. Ill., Judge Rebecca R. Pallmeyer), with significant parallel activity in state courts.
As of July 1, 2026 the federal docket held 810 pending cases. State-court juries have returned substantial verdicts in individual trials while defense wins have also occurred — a genuinely contested litigation whose scientific and regulatory record (including FDA and NIH attention to preterm nutrition) continues developing.
Claims remain allegations until adjudicated; nothing here implies feeding decisions were wrong — these are failure-to-warn claims about information parents and clinicians received.
Public-record events
Jul 1, 2026 · Other
Federal docket at 810 pending cases; state-court trials proceed in parallel.
View source ↗Apr 8, 2022 · Other
JPML centralizes preterm infant nutrition claims as MDL-3026.
View source ↗
Find the case for what you took or used
Open a case and answer a few questions in its free check. Only if you choose to can a law firm review your information.